Influence of metformin on metabolic effect of insulin in human adipose tissue in vitro. 1984

M Cigolini, and O Bosello, and C Zancanaro, and P G Orlandi, and O Fezzi, and U Smith

To study the mechanism(s) of action of metformin, fragments of human subcutaneous adipose tissue were incubated with therapeutic blood concentrations of metformin. In the absence of insulin no effect of metformin was seen on either lipolysis or glucose metabolism. When insulin was present, however, metformin stimulated glucose conversion into both triglycerides and CO2. In marked contrast, no effect of metformin was observed on the antilipolytic effect of insulin. In agreement with this selective effect no change in insulin binding was found. In conclusion, metformin seems to exert its effect on glucose metabolism by potentiating the action of insulin at a post-receptor level, possibly on the rate of glucose transport.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008066 Lipolysis The metabolic process of breaking down LIPIDS to release FREE FATTY ACIDS, the major oxidative fuel for the body. Lipolysis may involve dietary lipids in the DIGESTIVE TRACT, circulating lipids in the BLOOD, and stored lipids in the ADIPOSE TISSUE or the LIVER. A number of enzymes are involved in such lipid hydrolysis, such as LIPASE and LIPOPROTEIN LIPASE from various tissues. Lipolyses
D008297 Male Males
D008687 Metformin A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) Dimethylguanylguanidine,Dimethylbiguanidine,Glucophage,Metformin HCl,Metformin Hydrochloride,HCl, Metformin,Hydrochloride, Metformin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Cigolini, and O Bosello, and C Zancanaro, and P G Orlandi, and O Fezzi, and U Smith
October 1983, Diabetes,
M Cigolini, and O Bosello, and C Zancanaro, and P G Orlandi, and O Fezzi, and U Smith
November 1968, Diabetologia,
M Cigolini, and O Bosello, and C Zancanaro, and P G Orlandi, and O Fezzi, and U Smith
July 1965, Biochimica et biophysica acta,
M Cigolini, and O Bosello, and C Zancanaro, and P G Orlandi, and O Fezzi, and U Smith
November 1964, Canadian journal of biochemistry,
M Cigolini, and O Bosello, and C Zancanaro, and P G Orlandi, and O Fezzi, and U Smith
January 2011, Obesity facts,
M Cigolini, and O Bosello, and C Zancanaro, and P G Orlandi, and O Fezzi, and U Smith
March 1976, British journal of obstetrics and gynaecology,
M Cigolini, and O Bosello, and C Zancanaro, and P G Orlandi, and O Fezzi, and U Smith
January 1972, Diabetes,
M Cigolini, and O Bosello, and C Zancanaro, and P G Orlandi, and O Fezzi, and U Smith
April 1967, Acta medica Scandinavica,
M Cigolini, and O Bosello, and C Zancanaro, and P G Orlandi, and O Fezzi, and U Smith
April 1984, Diabetes,
M Cigolini, and O Bosello, and C Zancanaro, and P G Orlandi, and O Fezzi, and U Smith
September 2000, Biochemical and biophysical research communications,
Copied contents to your clipboard!